Patents for A61P 3 - Drugs for disorders of the metabolism (129,789)
10/2009
10/15/2009WO2009126527A1 2h-benzo[b][1,4]oxazin-3(4h)-one derivatives for use as stearoyl coa desaturase inhibitors
10/15/2009WO2009125873A1 Fused ring compounds and use thereof
10/15/2009WO2009125861A1 Cysteine protease inhibitor
10/15/2009WO2009125851A1 Method for detection of effectiveness of phenylalanine derivative-type compound in diabetes patient
10/15/2009WO2009125819A1 Aminosugar compound and process for production thereof
10/15/2009WO2009125434A2 Oxime derivatives
10/15/2009WO2009125140A2 Treatment of migraines without aura in pregnant women by inhalation of dioxygen gas
10/15/2009WO2009125017A2 Process for the extraction of mangiferin and isomangiferin
10/15/2009WO2009124950A2 4-methyl-4,5-dihydro-1h-pyrazole-3-carboxamide useful as a cannabinoid cb1 neutral antagonist
10/15/2009WO2009124638A1 Glucopyranoside derivatives
10/15/2009WO2009124636A1 Thienopyridone derivatives as amp-activated protein kinase (ampk) activators
10/15/2009WO2009124458A1 Phenylcyclobutylamide derivatives and their stereoisomers, the preparing processes and the uses thereof
10/15/2009WO2009093934A3 Substituted 3-sulphonyl-[1,2,3]triazolo [1,5-a]pyrimidines-antagonists of serotonin 5-ht6 receptors and methods for the production thereof
10/15/2009WO2009093269A9 Novel heterocyclic compounds
10/15/2009WO2009090210A3 Combination of metformin and an mtp inhibitor
10/15/2009WO2009086123A8 Imidazo [1,2-a] pyridine compounds
10/15/2009WO2009065920A3 Compounds
10/15/2009WO2009043465A3 Use of beta-endorphin as a therapeutic agent
10/15/2009WO2009033780A3 Use of growth hormone-releasing factor and/or k237 as a therapeutic agents
10/15/2009US20090258944 Method for the manufacture of therapeutic compounds and compositions, compounds and compositions produced therewith, and their use
10/15/2009US20090258931 Chimeric oligomeric compounds comprising alternating regions of northern and southern conformational geometry
10/15/2009US20090258921 Indole derivatives
10/15/2009US20090258919 Pharmaceutical formulations and use thereof in the prevention of stroke, diabetes and / or congestive heart failure
10/15/2009US20090258918 EP4 receptor agonist, compositions and methods thereof
10/15/2009US20090258913 Triazole Derivatives as Inhibitors of 11-Beta-Hydroxysteroid Dehydrogenase-1
10/15/2009US20090258902 Biphenyl-pyrazolecarboxamide compounds
10/15/2009US20090258901 Ligands for monoamine receptors and transporters, and methods of use thereof
10/15/2009US20090258900 Amide derivative
10/15/2009US20090258896 Composition comprising at least one higher aliphatic alcohol and an extract of griffonia simplicifolia
10/15/2009US20090258884 Substituted amides
10/15/2009US20090258881 Aryl-substituted polycyclic amines, method for the production thereof, and use thereof as a medicament
10/15/2009US20090258876 Novel indol carboxylic acid bispyridyl carboxamide derivatives, pharmaceutically acceptable salt thereof, preparation method and composition containing the same as an active ingredient
10/15/2009US20090258872 Use of aryl-substituted polycyclic amines as medicaments
10/15/2009US20090258871 Aza-Substituted Spiro Derivatives
10/15/2009US20090258856 Imidazopyridazinone and imidazopyridone derivatives, the preparation thereof and their use as pharmaceutical compositions
10/15/2009US20090258839 Compositions comprising chitosan suitable for comprehensive therapeutic treatment or comprehensive prevention of the metabolic syndrome
10/15/2009US20090258826 Pituitary adenylate cyclase activating peptide (PACAP) receptor (VPAC2) agonists and their pharmacological methods of use
10/15/2009US20090258818 Compositions For the Treatment of Diabetes
10/15/2009US20090258817 Arylsulfanyl compounds and compositions for delivering active agents
10/15/2009US20090258816 Use of gpcr agonists to delay progression of diabetes
10/15/2009US20090258422 Optically detectable organophosphonates
10/15/2009US20090258095 Use of a Ginkgo Biloba Extract for the Treatment of Mitochondrial Disease of Genetic Origin
10/15/2009US20090257998 Method for treating heart attacks, strokes and diabetic crisis by utilizing modified virus virions to insert necessary protein molecules and vital nutrients into targeted cells
10/15/2009US20090257996 Dietary supplement energy-providing to skeletal muscles and protecting the cardio vascular tract
10/15/2009US20090257982 medical device for treating diabetes mellitus, obesity, chronic fatigue, aging, and other medical conditions by utilizing modified virus virions to insert messenger ribonucleic acid molecules into cells
10/15/2009CA2721051A1 Aminosugar compound and process for production thereof
10/15/2009CA2721025A1 Thienopyridone derivatives as amp-activated protein kinase (ampk) activators
10/15/2009CA2720950A1 Compounds and compositions as modulators of gpr119 activity
10/15/2009CA2720686A1 Fused ring compounds and use thereof
10/15/2009CA2720586A1 Glucopyranoside derivatives
10/15/2009CA2719376A1 2h-benzo[b][1,4]oxazin-3(4h)-one derivatives for use as stearoyl coa desaturase inhibitors
10/15/2009CA2711212A1 Treatment of migraines without aura in pregnant women by inhalation of dioxygen gas
10/14/2009EP2108661A1 Metal salt of crosslinked cellulose derivative
10/14/2009EP2108649A1 Novel indol carboxylic acid bispyridyl carboxamide derivatives as 5-HT2c receptor antagonists
10/14/2009EP2108643A1 4-methyl-4, 5-dihydro-1H-pyrazole-3-carboxamide useful as a cannabinoid CB1 neutral antagonist
10/14/2009EP2108370A1 Formulation of a mixture of free-B-ring flavonoids and flavans as a therapeutic agent
10/14/2009EP2108016A1 2-anilino-4-heteroaryl pyrimidine derivatives, and preparation thereof as medicaments, pharmaceutical compositions, and in particular ikk inhibitors
10/14/2009EP2108015A1 Azacycloalkane derivatives as inhibitors of stearoyl-coenzyme a delta-9 desaturase
10/14/2009EP2107908A2 Use of a trpm5 inhibitor to regulate insulin and glp-1 release
10/14/2009EP1893603B1 Piperidin-4-yl-amide derivatives and their use as sst receptor subtype 5 antagonists
10/14/2009EP1856090B1 Substituted thiophene derivatives as glucagon receptor antagonists, preparation and therapeutic uses
10/14/2009EP1786774B1 Tricyclic lactam derivatives as 11-beta hydroxysteroid dehydrogenase inhibitors
10/14/2009EP1755604B1 Use of opioid receptor antagonist compounds for the prevention and/or treatment of diseases associated with the target calcineurin
10/14/2009EP1622897B1 Inhibitors of phosphatidylinositol 3-kinase
10/14/2009EP1461337B1 Pyrido¬2,1-a isoquinoline derivatives as dpp-iv inhibitors
10/14/2009EP1397137B1 Hydantion derivatives as inhibitors of matrix metalloproteinases
10/14/2009EP1356046B1 Cytokine receptor zcytor19
10/14/2009EP1337527B1 Indolylmaleimide derivatives as protein kinase c inhibitors
10/14/2009EP0830377B1 Glucagon-like peptide-2 and its therapeutic use
10/14/2009CN101558069A Cis-cyclohexyl substituted pyrimidinone derivatives
10/14/2009CN101558064A Sulfonyl-phenyl-2h-[1,2,4]oxodiazol-5-one derivatives, processes for their preparation and their use as pharmaceuticals
10/14/2009CN101555273A Ligand polypeptide combined with Tie2 protein specificity and drug delivery system
10/14/2009CN101555241A Ampelopsin pro-dug and preparing method and application thereof
10/14/2009CN101555214A Phenylcyclobutylacylamide derivative as well as optical isomer, preparation method and application thereof
10/14/2009CN101555202A Gemfibrozil polymorphism and preparation method thereof
10/14/2009CN101554473A Method for preparing compound with hypoglycemic function containing cornu cervi pantotrichum insulin-like active factors
10/14/2009CN101554445A Traditional Chinese medicine for treating diabetic hyperlipemia
10/14/2009CN101554444A Traditional Chinese medicine tea
10/14/2009CN101554436A Traditional Chinese medicine for treating diabetic stubborn insomnia
10/14/2009CN101554426A Traditional Chinese medicine for treating diabetic obstipation
10/14/2009CN101554418A Traditional Chinese medicine for treating diabetic peripheral neuritis
10/14/2009CN101554410A Quality control method of fresh fleece flower root and prepared fleece flower root
10/14/2009CN101554406A Extraction process and formulation of mulberry cortex hypoglycemic medicinal active material
10/14/2009CN101554404A Traditional Chinese medicine preparation for curing diabetes mellitus
10/14/2009CN101554396A Traditional Chinese medicine for treating diabetes and hyperlipidemia
10/14/2009CN101554387A Biological calcium carbonate extracting solution and production method thereof
10/14/2009CN101554385A Scalper bone chelate complex as well as preparation method and application thereof
10/14/2009CN101554374A Flavonoid compound with inhibit function for dipeptidyl peptidase IV
10/14/2009CN101554229A Thirsty-removing hypoglycemic egg and processing method thereof
10/14/2009CN101554228A Five-color hypoglycemic nutritional rice and processing method thereof
10/14/2009CN101554210A A process for decreasing environmental pollutants in an oil or a fat, a volatile environmental pollutants decreasing working fluid, a health supplement, and an animal feed product
10/14/2009CN101554197A Functional polysaccharide tea and preparation method thereof
10/14/2009CN101554196A Natural thirsty-removing hypoglycemic tea and processing method thereof
10/14/2009CN100549014C Triazolopyrimidine derivatives as glycogen synthase kinase 3 inhibitors
10/14/2009CN100548996C 5-phenylthiazole derivatives and its use for preparing medicine
10/14/2009CN100548985C N-aryl piperidine substituted biphenylcarboxamides as inhibitors of apolipoprotein B
10/14/2009CN100548369C Body fat percentage-lowering agent or body fat percentage increasing inhibitor
10/14/2009CN100548364C Morning oral administration Tibetan medicine for treating diabetes and its preparing method
10/14/2009CN100548342C Night oral administration Tibet medicine for treating diabetes and its preparing method
10/14/2009CN100548338C Traditional Chinese medicine preparation for treating gout